tiprankstipranks
Trending News
More News >
US Stem Cell (DE:BHV)
:BHV
Germany Market

US Stem Cell (BHV) Cash flow

Compare
0 Followers

US Stem Cell Cash Flow

DE:BHV's free cash flow for Q3 2023 was $0.00. For the 2023 fiscal year, DE:BHV's free cash flow was decreased by $753.09K and operating cash flow was $0.00. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -304.85K$ -1.06M$ -478.89K$ -1.21M$ 602.47K
Investing Cash Flow
$ 0.00$ 0.00$ 0.00$ 166.83K$ 311.70K
Financing Cash Flow
$ 270.59K$ 1.08M$ 497.46K$ -312.99K$ -543.82K
End Cash Position
$ 5.13K$ 39.39K$ 18.57K$ 0.00$ 1.36M
Free Cash Flow
$ -304.85K$ -1.06M$ -478.89K$ -1.38M$ 602.47K
Currency in USD

US Stem Cell Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis